In this video, Dr. Bernad, of Disney Family Cancer Center, discusses his experiences using the Xstrahl 100 device for treating skin cancer. https://youtu.be/x_oO7wdJ9LY This was recorded at Hope Cancer Center and comes from the website of Providence Health &...
Xstrahl 150 was used to treat Bowen's disease with a forehead lesion with no additional loss of hair or negative cosmetic impact.
Xstrahl 150 was successfully used to treat lentigo maligna with normal visual acuity post treatment and improved cosmesis.
In this case study, Xstrahl 150 was used to treat two patients with Cutaneous Squamous Cell Carcinoma.
Microbeam radiation is typically only available at large synchrotron facilities. SARRP brings this research into a regular laboratory, enabling researchers to study open physics and biology questions in this emerging field. See the results of this study, Evaluation of...
Nasal function and cosmesis are important considerations in the quality of life for nasal ala skin cancer patients. Surgery involves tissue loss, which is likely to lead to impaired function and undesired cosmetic results. Superficial radiotherapy can be an effective...
In this study, Minibeam Radiation Therapy at a Conventional Irradiator: Dose-Calculation Engine and First Tumor-Bearing Animals Irradiation, SARRP was modified to be adjustable for MBRT experiments. Researchers had the chance to conduct systematic and comprehensive...
[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting...
[:us]SARRP was vital in the study, Contrast Enhanced CBCT-Based Fractionated Radiotherapy and Followup Monitor of Orthotopic GBM: a Proof of Concept Study. Significant control of tumor growth and prolongation of mouse survival are clear indicators on the efficacy of...